Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1998
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053839A2 Anti-cancer products for treating cystic fibrosis
12/03/1998WO1998053838A2 A soluble laminin receptor precursor and methods to inhibit its interactions
12/03/1998WO1998053830A1 METHODS AND REAGENTS FOR MODULATING TGF-β SUPERFAMILY SIGNALING
12/03/1998WO1998053804A1 Methods and compositions for targeting compounds to muscle
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998053702A1 Method for treating a lactic raw material containing gmp
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998041636A3 Replication genes and gene products from small cryptic plasmids and methods for constructing high-copy number plasmid vectors
12/03/1998WO1998041631A3 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
12/03/1998WO1998040491A3 Pesticidal bacillus thuringiensis strains
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998039440A3 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF
12/03/1998WO1998038302A3 TETRODOTOXIN-SENSITIVE SODIUM CHANNEL α-SUBUNIT
12/03/1998WO1998035684A3 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus
12/03/1998WO1998035027A3 Human nerve growth factor exon 1 and exon 3 promoters
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19780012C2 Collection of haemo-lymph from insects
12/03/1998DE19722952A1 Use of polymers comprising units of fluorine atom(s) on carbon atom
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2292790A1 Human tumor necrosis factor receptor tr10
12/03/1998CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998CA2291894A1 Antimicrobial peptides derived from ubiquicidine
12/03/1998CA2291881A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291856A1 Cyclic crf antagonist peptides
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291720A1 Pharmaceutical compositions comprising a soluble laminin receptor precursor of a compound which blocks the interaction of the laminin receptor precursor and prpsc or prpc
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291510A1 Modulators of morphogen expression and methods of identifying the same
12/03/1998CA2291488A1 Collagen gel
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291323A1 Alternatively targeted adenovirus
12/03/1998CA2291278A1 Antigen delivery system
12/03/1998CA2291221A1 32 human secreted proteins
12/03/1998CA2291004A1 Immunological method
12/03/1998CA2290954A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998CA2290943A1 New human dp1 homolog
12/03/1998CA2289905A1 Hypersensitive response elicitor fragments and uses thereof
12/03/1998CA2288971A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
12/03/1998CA2288967A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881291A2 CBS2 polypeptides, members of the guanine exchange factor family
12/02/1998EP0881290A2 Neurotransmitter transporter HPDDV78
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881288A1 Purification of higher order transcription complexes from transgenic non-human animals
12/02/1998EP0881286A2 Histidine kinase
12/02/1998EP0881231A2 HCV peptide-antigens and a method of testing for the hepatitis C virus
12/02/1998EP0881228A2 2- or 3-dimensional geometric structures
12/02/1998EP0880902A1 Process for treating a raw whey material
12/02/1998EP0880703A2 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule
12/02/1998EP0880701A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880596A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells
12/02/1998EP0880591A1 Thrombin muteins as antidotes for thrombin inhibitors
12/02/1998EP0880589A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880588A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880587A1 Gene therapy method using fgf-5
12/02/1998EP0880586A1 Lyst1 and lyst2 gene compositions and methods of use
12/02/1998EP0880584A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
12/02/1998EP0880583A1 Estrogen response element binding proteins and nucleotides encoding therefor
12/02/1998EP0880543A1 Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates
12/02/1998EP0880542A2 Substrates and inhibitors for cysteine protease ich-1
12/02/1998EP0880361A1 Immunogenic detoxified mutants of cholera toxin
12/02/1998EP0880356A1 Antimicrobial peptides and methods of use
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0784424A4 Cytoplasmic male sterility system producing canola hybrids
12/02/1998EP0771210A4 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ -g(g)1 CHAIN
12/02/1998EP0754241B1 Hibridization-ligation assays for the detection of specific nucleic acid sequences
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0750635B1 Peptides inhibiting the release of pepsine
12/02/1998EP0717753B1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
12/02/1998EP0691986B1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
12/02/1998EP0655162B1 Compositions of bacteriorhodopsin variants with increased memory time and their use
12/02/1998EP0599913B1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same
12/02/1998EP0597838B1 Vaccine compositions
12/02/1998EP0542887B1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia
12/02/1998EP0528870B1 Protein-nucleic acid probes and immunoassays using same
12/02/1998EP0527839B1 Recombinant library screening methods
12/02/1998EP0527785B1 Improvements relating to the detection of viruses
12/02/1998CN1200763A New adhesion from helicobactor pylori
12/02/1998CN1200680A Novel attinity ligands and their use
12/02/1998CN1200674A Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
12/02/1998CN1200235A Purificn. of higher order transcription complexes from transgenic non-human animals
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/02/1998CA2224407A1 Genes controlling floral development and apical dominance in plants
12/01/1998US5844119 Genetically modified plants having modulated flower development
12/01/1998US5844107 Compacted nucleic acids and their delivery to cells
12/01/1998US5844099 Cytokine antagonists
12/01/1998US5844098 Reconstituted platelet membrane vesicles
12/01/1998US5844096 Methods for inhibiting transcription of the cyclic AMP responsive element binding protein and the activating transcription factor 1
12/01/1998US5844095 CTLA4 Ig fusion proteins
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844091 Antibody having binding specificity for human ouabain
12/01/1998US5844090 Modified hemoglobin-like compounds
1 ... 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 ... 2916